Identification
RX-3341; WQ-3034; ABT492; Delafloxacin
Molecular Formula:
C18H12ClF3N4O4
Synonym:
3-Quinolinecarboxylic acid, 1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxy-1-azetidinyl)-4-oxo- ; 1-(6-Amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid ;
Suppliers
CAS equal suppliers
ABT492
ShangHai Biochempartner Co., Ltd.
BCP21227
ABT-492
Xingrui Industry Co., Limited
XIL203812
ABT-492
Chemlyte Solutions
CS126378
Delafloxacin
Hangzhou MolCore BioPharmatech Co.,Ltd.
MC10497
Delafloxacin
Leap Chem Co., Ltd
LC216648
Delafloxacin
LGM Pharma
LP120360
Delafloxacin
Ambeed, Inc.
A139239
Delafloxacin
CSNpharm, Inc.
CSN16520
Delafloxacin
BoomKing Industrial Co.,Limited
BIC3721488
Delafloxacin
H&Z Industry Co.,Ltd
HIC240960
Delafloxacin
Aozeal Certified Standards (AOCS), Inc.
D0212.00
Delafloxacin
Conscientia Industrial Co., Ltd (Zhejiang Conscientia Pharmaceutical)
CI8283312
Delafloxacin
Aea.ltd
A84168
1-(6-Amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
BLD Pharmatech Ltd
BP34020102060
Prices & Availability
Data is processed
x
Properties for RX-3341; WQ-3034; ABT492; Delafloxacin
Molecular Weight:
440.76 g·mol−1
Boiling point:
698.5 °C at 760 mmHg
x
Hazard Statements
GHS03
Harmful
- Acute toxicity (oral, dermal, inhalation), category 4
- Skin irritation, categories 2, 3
- Eye irritation, category 2A
- Skin sensitization, category 1
- Specific target organ toxicity following single exposure, category 3
- Respiratory tract irritation
- Narcotic effects
Not used
- with the "skull and crossbones" pictogram
- for skin or eye irritation if:
- the "corrosion" pictogram also appears
- the "health hazard" pictogram is used to indicate respiratory sensitization
Safety & Transport Information
x
Alternative Distributors of [RX-3341; WQ-3034; ABT492; Delafloxacin]
Producers or manufacturers change the product range from time to time.
Currently there are no other manufacturers known.